Radiation Oncology is dedicated to patient care, research and teaching, as related to the medical use of ionizing radiation in patients with cancer.
Services are offered on a tumour site-specific basis, with a strong emphasis on multidisciplinary care and optimal utilization of radiotherapy, using the very latest in image-based techniques for treatment. Radiation Oncology has been at the forefront of technology assessment and development and is a world leader in areas such as high dose rate brachytherapy, stereotactic radiation, and conformal and intensity modulated treatment. There are also strong clinical and translational research programs, and a leadership role has been established in the development of academic programs.
Research programs are active in the following areas:
- Clinical—including technology assessment, and development of techniques and trials;
- Physics—including radiation dosimetry and image processing;
- Biology—including chemotherapy-radiotherapy interactions and delivery mechanisms, and DNA repair mechanisms.
The establishment of a radiation sciences research group, which brings together individuals involved in translational research in radiation oncology, has led to a number of new interdisciplinary research ventures that include application of Monte Carlo dosimetry in the development of new radiation techniques and physical and biological modulation of radiation effects on tumours and normal tissues. McGill Centre for Translational Research in Cancer
Radiation Oncology is based at the MUHC-Montreal General Hospital and at the Sir Mortimer B. Davis Jewish General Hospital.
|Associate Director:||Dr. Té Vuong
(514) 340-8222 x 2073
(514) 934-1934, x43164